ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Imprimis Pharmaceuticals, Inc. (delisted)

Imprimis Pharmaceuticals, Inc. (delisted) (IMMY)

5.69
0.00
( 0.00% )
Updated: 20:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
5.69
Bid
5.60
Ask
6.00
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
5.69
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

IMMY Latest News

ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting

SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its...

Harrow Health Announces Fourth Quarter 2018 Financial Results

SAN DIEGO, March 12, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the fourth quarter 2018. Fourth Quarter 2018 and Other Recent Notable Highlights:...

Harrow Health to Attend 31st Annual ROTH Conference on March 18, 2019

SAN DIEGO, March 04, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that it will be attending the 31st Annual ROTH Conference March 18-19, 2019 at The Ritz Carlton...

Harrow Health to Announce Fourth Quarter 2018 Financial Results on March 12, 2019

SAN DIEGO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced it will release fourth quarter 2018 financial results after the close of trading on Tuesday...

Melt Pharmaceuticals Improves Patent Estate for Sublingual Non-Opioid Pain and Sedation Formulations

SAN DIEGO and BOSTON, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., a specialty pharmaceutical company recently deconsolidated from Harrow Health, Inc. (NASDAQ: HROW), today...

Harrow Health Subsidiary, Mayfield Pharmaceuticals, Inc., Acquires Patented Dyspareunia Drug Candidate and Other Intellectual...

SAN DIEGO, Feb. 07, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), today announced that its subsidiary, Mayfield Pharmaceuticals, Inc., has acquired drug formulation assets and...

Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary

SAN DIEGO and BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, Inc., an affiliated company of Harrow Health, Inc. (NASDAQ: HROW), today announced it has entered into definitive...

Imprimis Pharmaceuticals, Inc. Completes Name Change to Harrow Health, Inc.

SAN DIEGO, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (formerly known as Imprimis Pharmaceuticals, Inc.) (NASDAQ: IMMY) announced it has formally changed its name and that it will...

Imprimis Pharmaceuticals Ranked 88th Fastest Growing Company in North America on Deloitte’s 2018 Technology Fast 500™

Imprimis attributes growth to its vision of making sure patients have access to high quality affordable medications   SAN DIEGO, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals...

Imprimis Pharmaceuticals Announces Third Quarter 2018 Results

SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) today reported results for the third quarter 2018. Third Quarter 2018 and Other Recent Notable...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KAVLKaival Brands Innovations Group Inc
$ 1.4401
(148.72%)
153.99M
LASELaser Photonics Corporation
$ 17.423
(67.37%)
7.37M
TGLTreasure Global Inc
$ 1.12
(64.63%)
128.8M
NVVENuvve Holding Corporation
$ 5.89
(50.26%)
27.71M
UXINUxin Ltd
$ 2.37
(49.53%)
11.72M
ELABElevai Labs Inc
$ 0.1109
(-60.39%)
13.33M
ADTXAditxt Inc
$ 0.269
(-29.69%)
2.05M
FRGTFreight Technologies Inc
$ 0.0805
(-29.26%)
21.84M
ZJYLJin Medical International Ltd
$ 2.8901
(-29.16%)
726.53k
ANEBAnebulo Pharmaceuticals Inc
$ 2.34
(-24.03%)
89.04k
XPONExpion360 Inc
$ 0.107631
(26.92%)
364.45M
KAVLKaival Brands Innovations Group Inc
$ 1.4401
(148.72%)
153.99M
TGLTreasure Global Inc
$ 1.12
(64.63%)
128.8M
NVDANVIDIA Corporation
$ 115.56
(-0.38%)
119.51M
INTCIntel Corporation
$ 22.5499
(3.25%)
111.84M

Discussion

View Full Feed
BIOCHEMUP BIOCHEMUP 2 minutes ago
Nice about one million bought at 0.002.
RSPI
crazy horse 0 crazy horse 0 2 minutes ago
What a Stupid people these are

https://x.com/snoopsmom123/status/1794552738891600288
gp22 gp22 2 minutes ago
VVOS @ $3.03: The #1 medical device play to own now. Offering closed Friday. News due. Should pop nicely with DFA approval out last week.
VVOS
Mark Mark 2 minutes ago
$RSLS 8.72 halted up
RSLS
gp22 gp22 3 minutes ago
VVOS @ $3.03: The #1 medical device play to own now. Offering closed Friday. News due. Should pop nicely with FDA approval out last week.
VVOS
PioneerPhoenix73 PioneerPhoenix73 3 minutes ago
Debunking the Audi e-Tron GT Fire Conspiracy Theory: Separating Fact from Fiction

The recent Audi e-Tron GT fire in Indiana is concerning, but attributing it to a geomagnetic storm and electromagnetic fields (EMF) is not supported by scientific evidence. Here's a breakdown:
TSLA
JJ8 JJ8 3 minutes ago
Palantir share price Ascending Triple Top Breakout today on 23-Sep-2024.

This follows the Double Top Breakout of 12-Sep-2024 and it seems like a clue of reinforcing the previous message.

We shall see. Strange the same type of clues are showing in several shares of othe
PLTR
cojoboy cojoboy 3 minutes ago
Wow..???.I knew they were going to walk this down...but..did not see them running..lol
IGPK
facts_matter14 facts_matter14 3 minutes ago
Easiest way to make money is to short whatever she pumps, as it’s guaranteed to drop at least 75% from when she jumps in.


.
MAXN
ProfitScout ProfitScout 3 minutes ago
$NRXP News: NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

"How NRx Could Upend the Fight Against Depression and Suicide"

RADNOR, Pa., Sept. 11, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical compa
NRXP
Mark Mark 3 minutes ago
$RSLS 8.45
RSLS
Triple nickle Triple nickle 4 minutes ago
Look out 20 bucks
Walter4 Walter4 4 minutes ago
You need a miracle. Hoping and waiting for this kid who's publicly known for shady schemes to run another pump and dump is no strategy.
BCAP
biowin biowin 4 minutes ago
Because the trust only deals with government securities and Bioamber is a government owned company built on green bonds, Sarnia's plant was built by the Government of Ontario , Bioamber US was developed in the Department of Energy also in Europe, I guess we have two referees working as a team here
crossball crossball 4 minutes ago
OK, can I use the word interesting. Can I add.....*Mark, you are a very handsome man emitting from the profile pic.


*perspective can change on future events.
STHC
stealofadeal stealofadeal 4 minutes ago
$MGON You need to get some videos and a good man like Steve Conboy to sell that product. Don’t infringe on his many patents though.

https://youtu.be/T6D0T0Javt0?si=T5_XXojCt6Ujg9sI
MGON
sloppyjones sloppyjones 4 minutes ago
I like big but(t)s and I cannot lie...
TPTW
okwife okwife 4 minutes ago
RNVA??? RNVA IS EXPERT MARKET!!! SO WHEN WILL IT GO PINK AGAIN? AND WHEN IS THE R/S?AND IT IS A LOW FLOATER? https://www.otcmarkets.com/stock/RNVA/security
COME ON MAN!!
RNVA
my3sons87 my3sons87 4 minutes ago
At this time we are waiting on the IDCC and Samsung arbitration rate decision for wireless devices which will be for the period commencing Jan 1, 2023 forward. In addition Samsung is licensed for their televisions,

We are still fighting it out with Lenovo in the US and India. And Oppo
IDCC
PRmaniac PRmaniac 4 minutes ago
Just confirmed - massive dilution - read my previous post.
AAPJ is known for dilution and not being a viable entity.
Just surviving on dilutive share issuance.
AAPJ
AugustaFriends AugustaFriends 4 minutes ago
$LUXH insiders buying does not mean anything, if they are dilution millions... that is just a scheme to get buyers interest... if they buy $10,000 worth of insider buy... but dump $1 Million worth of shares via dilution.. it would get People like us to buy.. like WOW insiders are buying... Be caref
LUXH
PonkenPlonken PonkenPlonken 4 minutes ago
POET 4.31
ANTI-BAGHOLDER ANTI-BAGHOLDER 4 minutes ago
New highs yet again… good job.
MONI
exwannabe exwannabe 4 minutes ago
You mean like my bets on significant revenue in past years and approval by 2023 summer , 2024 august? I must have missed the news on those.

There is exactly one where I was surprised and admit being wrong. I did think they would not get into a JAMA level journal w/o significantly cle
NWBO
ProfitScout ProfitScout 4 minutes ago
$NRXP News: NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Featured on Psychiatrist.com

"How NRx Could Upend the Fight Against Depression and Suicide"

RADNOR, Pa., Sept. 11, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical compa
NRXP

Your Recent History

Delayed Upgrade Clock